NEED DRUG INFORMATION? There s an app for that

Size: px
Start display at page:

Download "NEED DRUG INFORMATION? There s an app for that"

Transcription

1 NEED DRUG INFORMATION? There s an app for that Conor Hanrahan, PharmD, BCPS Drug Information Specialist Intermountain Healthcare conor.hanrahan@imail.org April 16, 2015 DISCLOSURES Conor Hanrahan has no financial or personal relationships to disclose Will not discuss off-label uses OBJECTIVES Explain the role of mobile applications in medical practice. Explain current standards and regulations used to manage mobile medical applications. Describe key critical assessment skills needed to effectively evaluate a drug information resource. Identify mobile drug information applications that are beneficial for pharmacists in their practice setting. 1

2 4/13/15 DISCLAIMERS Mobile apps are changing rapidly Will only discuss apps focused on providing drug information The apps included do not represent an exhaustive list Images courtesy of GROWTH OF MEDICAL APPS Estimated 20,000 to 40,000 medical apps 44-million mobile health app downloads in 2012 Over $1.3 billion in annual revenue Projections 500-million people will use a medical app by 2015 Over $20 billion in mobile health sales by 2017 Student BMJ. 2012;20:e2162. Evid Based Med Jun;18(3):90-2. AAMC Reporter Available from: [click here] 2

3 SCOPE OF MEDICAL APPS Search medication databases View guidelines and consensus statements Educate patients, students, residents, etc. Perform medical calculations Assist with diagnosis and treatment decisions Remotely monitor patients DEVELOPERS OF MEDICAL APPS Individuals (medical and non-medical) Pharmaceutical companies Insurance companies Non-profit and for-profit organizations Governmental bodies BENEFITS Real-time information at the patient s bedside Improved communication Improved efficiency Better clinical decision making Visser BJ, et al. Student BMJ. 2012;20:e2162. Buijink AW, et al. Evid Based Med Jun;18(3):90-2. Mosa AS, et al. BMC Med Inform Decis Mak Jul 10;12:67. 3

4 POTENTIAL DANGERS Inaccurate, misleading, or unreliable information Pfizer rheumatology calculator app recall Apps for melanoma detection Apps for cancer information J Canc Educ. 2013;28: JAMA Dermatol Apr;149(4): Evid Based Med Jun;18(3):90-2. POTENTIAL DANGERS Lack of involvement from medical professionals Opioid conversion apps 52% were not associated with a health care professional 35% did not recommend empiric dose reduction Haffey F, et al. Drug Saf. 2013;36: Buijink AW, et al. Evid Based Med Jun;18(3):90-2. GOVERNMENT OVERSIGHT Limited regulation of medical apps Food and Drug Administration Finalized guidance for mobile medical apps in 2013 Outlines how regulatory authority will be applied Certain apps will be considered a medical device FDA Guidance: Mobile Medical Applications, Available from: [CLICK] 4

5 REGULATED APPS Control other medical devices Display, store, analyze, or transmit patient-specific medical data from another medical device Use attachments, display screens, or sensors to transform the mobile platform into a device Perform patient-specific analyses and provide a patientspecific diagnosis or treatment recommendation FDA Guidance: Mobile Medical Applications, Available from: [CLICK] ENFORCEMENT DISCRETION Provide or facilitate supplemental care by coaching or prompting patients Tools to help patients organize or track health information Provide access to information related to health conditions or treatments Allow patients to communicate medical conditions with providers Perform simple calculations used in clinical practice Enable individuals to interact with electronic health records FDA Guidance: Mobile Medical Applications, Available from: [CLICK] NOT REGULATED BY FDA Electronic copies of medical textbooks, teaching aids, or other reference materials Intended as educational tools for medical training Facilitate patient access or understanding Automate general office operations Not specifically designed for medical purposes FDA Guidance: Mobile Medical Applications, Available from: [CLICK] 5

6 QUESTION 1 Which of the following is an example of a mobile medical app that would require approval as a medical device by FDA? A. An app that provides pharmacists access to treatment guidelines from the American Diabetes Association. B. An app that lets a patient with type I diabetes control the flow rate of his or her insulin pump. C. An app that helps remind a patient to take his or her diabetes medication. D. An app that provides medical residents with general, non-patient specific dosing information for common diabetes medications. A Roadmap for EVALUATING APPS USEFULNESS Can you see it being useful in your daily work? Is it relevant to your scope of practice? Will it make your job easier or more efficient? 6

7 ACCURACY Is the clinical content based on evidence? Is the content referenced? Are the references appropriate? Do you consider the content to be complete and comprehensive? ACCURACY Qx Calculate (QxMD Medical Software) Critical Care Emergencies (Anna Chan) AUTHORITY Are the creators or developers reputable? Are the creators medically trained or content experts in the area? Consider doing a literature search What other apps have they developed? Is their contact information available? 7

8 AUTHORITY Anticoag Evaluator (American College of Cardiology) Coagulate (LJ Cubed Apps) AUTHORITY Can be difficult to find Check the download page or developer page Check within the app OBJECTIVITY Is the content fair and balanced? Does the app show multiple view points? Could the developer be biased? Does the app use clinical data for promotional purposes? 8

9 OBJECTIVITY iclot (Cranworth Medical Ltd.) TIMELINESS Does the clinical content reflect the most recent information? Is the app updated regularly? Manual or automatic updates Version history on download page TIMELINESS Lexicomp (Lexi-Comp, Inc.) Micromedex (Truven Health Analytics) 9

10 FUNCTIONALITY Does the app install, launch, and operate consistently? Does the app freeze? Does material download appropriately? Are there technical glitches? FUNCTIONALITY Pharmacist s Letter (Therapeutics Research Center) DESIGN Does the design add to or hurt functionality? Are graphics, layout, and terminology consistent? Is text sized and spaced appropriately? Are things presented in a clean, uncluttered way? Are buttons easy to understand? 10

11 DESIGN Pharmacist s Letter (Therapeutics Research Center) Medscape (WebMD) SECURITY Is the app free of malicious software? Is there a privacy statement? Is personal information protected? HIPAA compliance? VALUE How much does the app cost? Is the price reasonable compared with other products? Do the overall benefits outweigh the limitations? 11

12 4/13/15 VALUE Tarascon Pharmacopeia (USBMIS, Inc.) Medscape (WebMD) ADDITIONAL RESOURCES imedicalapp.com MedicalAppJournal.com QUESTION 2 You are evaluating a mobile app designed to help you choose an appropriate chemotherapy regimen. Which one of the following apps would be considered the MOST appropriate to use? A. An app developed by an oncology fellow that references national treatment guidelines, but has not been updated since B. An app developed by a computer scientist from the Massachusetts Institute of Technology (MIT), which references various chemotherapy textbooks. C. An app developed by the National Comprehensive Cancer Network (NCCN) that is updated weekly and references current treatment guidelines and primary literature. D. An app that references current treatment guidelines, is updated monthly, but does not provide any information regarding authorship. 12

13 Image: DRUG INFO General Resources OVERVIEW OF APP RESOURCES Lexicomp Micromedex Clin Pharm Epocrates Medscape Skyscape Adult General DI* Pediatric General DI* Drug Interactions Drug Identificaiton IV Compatibility Calculators Toxicology Data storage Device Device Device Device Device** Device Systems * Includes drug dosing, adverse effects, warnings, contraindications, pharmacokinetics, preparations, etc. ** Can also choose to keep data stored on the Internet instead of the device Minimal information included within drug monographs 13

14 APP DRUG MONOGRAPHS Lexicomp Micromedex Clin Pharm Epocrates Medscape Skyscape Uses Dosing Administration Side Effects Cautions Monitoring Interactions MOA ADME Storage Dosage Forms Drug Pricing ADME = absorption, distribution, metabolism, and excretion; MOA = mechanism of action LEXICOMP DATABASES Lexi-Drugs Pediatric & Neonatal Lexi-Drugs Lexi-IV Compatibility Lexi-Interact Lexi-Drug ID Lexi-CALC LEXI-DRUGS 14

15 LEXI-DRUGS Charts and special topics Chemotherapy regimens Black box warnings REMS medication list LEXI-INTERACT Severity, onset, and documentation Summary and detailed discussion Management strategies References available LEXI-IV COMPATIBILITY Based on Trissel s IV-Chek Y-site, syringe, and admixtures Summary of studies Individual drug properties References available 15

16 LEXICOMP PRICING Software packages from $115 to $595 per year Individual databases for $75 each per year LEXICOMP SUMMARY Reputation Strengths Thorough information that is easy to comprehend Comparable with the online database Easy/intuitive interface Limitations Manual updates Some awkward formatting on small screens Expensive Drug Information Drug Interactions IV Compatibility Pediatric Essentials NeoFax Essentials MICROMEDEX APPS 16

17 MICROMEDEX MONOGRAPHS MICROMEDEX INTERACTIONS Severity, onset, and documentation Summary Clinical management Full references not available MICROMEDEX COMPATIBILITY Based on Trissel s 2 IV Compatibility database Y-site and admixtures Study details but no specific references 17

18 MICROMEDEX PRICING Free to institutional/online subscribers (need code) $2.99 to $30 per year for individuals MICROMEDEX SUMMARY Strengths Reputation Inexpensive Easy to use and navigate Automatic updates Limitations Drug information is basic Lacks features found in similar products Separate app for each database CLINICAL PHARMACOLOGY Drugs Interactions 18

19 4/13/15 CLIN PHARM MONOGRAPHS DRUG INTERACTIONS Severity and documentation Summary Clinical management Full references not available CLIN PHARM PRICING Only available to institutional/online subscribers (need to create username and password) 19

20 CLIN PHARM SUMMARY Strengths Very simple interface Detailed drug monographs Reputable reference Free Limitations Missing other databases/ resources Interaction checker helpful, but not as detailed Monographs can be text heavy EPOCRATES RX DATABASES Drugs Interaction Check Pill ID Calculators Drug Tables EPOCRATES DRUGS 20

21 EPOCRATES INTERACTION CHECK Simple interface Minimal information on effect and management No references OTHER NOTABLE RESOURCES Tables and special drug topics Drug manufacturer directory EPOCRATES PRICING Epocrates Rx is free Must register for an account Epocrates Essentials is $160 per year 21

22 EPOCRATES SUMMARY Strengths Very simple interface Several unique resources Free Limitations Drug monographs are basic compared with other products Lacks information on IV administration and compatibility Interaction checker lacks detail and references MEDSCAPE DATABASES Drugs Interaction Checker Calculators MEDSCAPE DRUGS 22

23 MEDSCAPE INTERACTION CHECKER Simple interface Minimal details Vague or no management suggestions No references Free MEDSCAPE PRICING Must register for an account MEDSCAPE SUMMARY Strengths Relatively detailed drug information Monograph information is easy to read Intuitive interface Limitations Little detail in drug interaction checker Content not referenced Advertisements Free 23

24 SKYSCAPE / OMNIO DATABASES SkyscapeRx Interaction Checker Calculator (Archimedes) (ipad) SKYSCAPERX SKYSCAPE INTERACTION CHECKER Uses data from Hansten and Horn s Drug Interactions Often lacks specific management strategies No references 24

25 SKYSCAPE / OMNIO PRICING RxDrugs and Interaction Checker are free Must register for an account Other in-app drug resources can be purchased SKYSCAPE SUMMARY Strengths Relatively detailed drug information Monograph information is easy to read Free Limitations Little information on administration, monitoring, and storage Basic information in drug interaction checker QUESTION 3 You are rounding with your internal medicine team when one of the residents asks you which mobile drug app would be best to use for general drug information on rounds. You correctly tell him which of the following? A. To use Epocrates because it is free and contains detailed information on dosing, adverse effects, and IV administration. B. To use Medscape because it is internally referenced and has supplemental tools, such as an IV compatibility checker. C. To use Micromedex because it contains the same detailed DRUGDEX information found in the online version. D. To use Lexicomp because it contains detailed information, is internally referenced, and has an intuitive user interface. 25

26 4/13/15 OTHER APPS General Drug Information DRUG INFO Infectious Diseases SUMMARY Drug information apps can be an important clinical tool Use and prevalence will continue to increase It is important to critically evaluate apps before using them in clinical practice 26

27 HAVE QUESTIONS? There s probably an app for that too Conor Hanrahan, PharmD, BCPS Drug Information Specialist Intermountain Healthcare conor.hanrahan@imail.org 27

Lexicomp Online. USER GUIDE Table of Contents. Drug Information

Lexicomp Online. USER GUIDE Table of Contents. Drug Information Drug Information Lexicomp Online USER GUIDE Table of Contents THE LEXICOMP ONLINE HOME PAGE Searching from the Home Page... 3 Limiting Searches within Monograph Sections... 4 Explore by General Category...

More information

Electronic Medical Records. Centricity EMR 9.2 ---------- Medication Monographs & Dosing Calculator

Electronic Medical Records. Centricity EMR 9.2 ---------- Medication Monographs & Dosing Calculator Electronic Medical Records Centricity EMR 9.2 ---------- Medication Monographs & Dosing Calculator MEDICATION MONOGRAPHS & DOSING CALCULATOR PURPOSE The intent of this document is to inform and instruct

More information

7/4/2013. + Presenter Information. Evaluating Mobile Medical Applications For Utilization By Pharmacy Students. Email: Timothy.Aungst@MCPHS.

7/4/2013. + Presenter Information. Evaluating Mobile Medical Applications For Utilization By Pharmacy Students. Email: Timothy.Aungst@MCPHS. Evaluating Mobile Medical Applications For Utilization By Pharmacy Students Timothy Dy Aungst, PharmD MCPHS University Presenter Information Email: Timothy.Aungst@MCPHS.edu Twitter: @TDAungst Affiliations:

More information

Objectives: What it is. There s an App for That : Evidence Based Integration of Technology into Physical Therapy Practice 11/6/2013

Objectives: What it is. There s an App for That : Evidence Based Integration of Technology into Physical Therapy Practice 11/6/2013 There s an App for That : Evidence Based Integration of Technology into Physical Therapy Practice Jena Ogston, PhD, PT Associate Professor College of St. Scholastica Physical Therapy Program This information

More information

MOBILE MEDICAL APPLICATIONS

MOBILE MEDICAL APPLICATIONS October 7, 2013 EVOKE HEALTH POINT OF VIEW MOBILE MEDICAL APPLICATIONS FDA GUIDANCE FOR INDUSTRY FOR MORE INFORMATION: Mark McConaghy, VP, Strategy Evoke Health 267.765.4998 mark.mcconaghy@evokehealth.com

More information

Master's Clinical Pharmacy (Thesis Track)

Master's Clinical Pharmacy (Thesis Track) Master's Clinical Pharmacy (Thesis Track) I. GENERAL RULES CONDITIONS: Plan Number 3 \ 12 06 2010 T 1. This plan conforms to the valid regulations of the programs of graduate studies. 2. Areas of specialty

More information

Templates. FDA Mobile Medical App Regulations. Your own sub headline This is an example text. Your Logo

Templates. FDA Mobile Medical App Regulations. Your own sub headline This is an example text. Your Logo Templates FDA Mobile Medical App Regulations Your own sub headline This is an example text Your Logo FDA Oversight of Medical Devices The latest Guidance from the FDA Tom Richards MD/MS trichards0445@me.com

More information

FDA Regulation of Health IT

FDA Regulation of Health IT FDA Regulation of Health IT May 2014 Marian J. Lee Partner King & Spalding +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDASIA Health IT Report 2 FDA s Mobile Medical

More information

The U.S. FDA s Regulation and Oversight of Mobile Medical Applications

The U.S. FDA s Regulation and Oversight of Mobile Medical Applications The U.S. FDA s Regulation and Oversight of Mobile Medical Applications The U.S. FDA s Regulation and Oversight of Mobile Medical Applications As smart phones and portable tablet computers become the preferred

More information

Basic Reference Format

Basic Reference Format Basic Reference Format The following Referencing Format is adapted from the AMA Manual of Style, 9 th edition. 1 If you have questions about referencing an item, please refer to the AMA Manual of Style,

More information

Mobile Apps & Pediatric Subspecialists

Mobile Apps & Pediatric Subspecialists WHITE PAPER Mobile Apps & the Pediatric Subspecialist Using Calculators, Test and Diagnostic Differentials, and Medical Illustrations at the Point of Care July 2014 DOBIES Healthcare Group DOBIES HEALTHCARE

More information

Loss Control Webinar Series. Mobile Medical Apps: FDA Regulation and Products Liability Implications 10-23-2013

Loss Control Webinar Series. Mobile Medical Apps: FDA Regulation and Products Liability Implications 10-23-2013 Loss Control Webinar Series Mobile Medical Apps: FDA Regulation and Products Liability Implications 10-23-2013 www.goldbergsegalla.com NEW YORK PENNSYLVANIA CONNECTICUT NEW JERSEY UNITED KINGDOM Mobile

More information

FDA Issues Final Guidance on Mobile Medical Apps

FDA Issues Final Guidance on Mobile Medical Apps ADVISORY September 2013 FDA Issues Final Guidance on Mobile Medical Apps On September 23, 2013, the U.S. Food & Drug Administration (FDA or the Agency) issued its final Guidance for Industry and Food and

More information

How To Use An Mhealth App On Iphone Or Ipad

How To Use An Mhealth App On Iphone Or Ipad Medical Applications for the iphone Navigating in a World of Apps Lori Fitterling, MLS Digital Services/Reference Librarian Homecoming, CME September 19, 2015 What is an App Anyway? Computer programs or

More information

FDA Regulation of Health IT

FDA Regulation of Health IT FDA Regulation of Health IT September 2014 Marian J. Lee Partner +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDA Draft Guidance on Medical Device Data Systems (MDDS),

More information

Mobile Medical Application Development: FDA Regulation

Mobile Medical Application Development: FDA Regulation Mobile Medical Application Development: FDA Regulation Mobile Medical Applications: Current Environment Currently over 100,000 mobile health related applications are available for download; there is an

More information

Disclosures. Optimizing Alerts within Electronic Health Records 8/3/2015. 49th Annual Meeting. Objectives Pharmacist & Technician

Disclosures. Optimizing Alerts within Electronic Health Records 8/3/2015. 49th Annual Meeting. Objectives Pharmacist & Technician 49th Annual Meeting Disclosures Optimizing Alerts within Electronic Health Records Arti N. Bhavsar, Pharm.D., August 8 th, 2015, FSHP Annual Meeting OWNING CHANGE: Taking Charge of Your Profession Disclosure

More information

Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER

Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER LT Andrew Fine, Pharm.D., BCPS Safety Evaluator Division of Pharmacovigilance Office of Pharmacovigilance and Epidemiology

More information

Mobile Medical Applications

Mobile Medical Applications Mobile Medical Applications What Is the Impact of FDA s New MMA Guidance for the Life Science Industry? June 6, 2014, 11:15 AM 12:15 PM Presented by: Mark Gardner, M.B.A., J.D. Agenda 1. How does FDA regulate

More information

Activating Standardization Bodies Around Medical Apps

Activating Standardization Bodies Around Medical Apps Activating Standardization Bodies Around Medical Apps Michael J. Ackerman, Ph.D. Assistant Director High Performance Computing and Communications U.S. National Library of Medicine The views and opinions

More information

University of Louisville Hospital PGY1 Pharmacy Residency Program Summary

University of Louisville Hospital PGY1 Pharmacy Residency Program Summary University of Louisville Hospital PGY1 Pharmacy Residency Program Summary Positions Available: 4 positions, 12 month contract Application Deadline: Early January (see PhORCAS) Requirements: On-site Interview,

More information

Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program

Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program Pediatric Pharmacy Residency Program (PGY1) Children s Hospital Central California offers a one-year, postgraduate residency program

More information

Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications

Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications 2015 Annual Conference Washington, DC Bakul Patel, Associate Director for Digital Health, Office of Center Director, Center

More information

Potential for Apps in Pharmaceutical Development. Steve Hutson Co-founder Virtual PV

Potential for Apps in Pharmaceutical Development. Steve Hutson Co-founder Virtual PV Potential for Apps in Pharmaceutical Development Steve Hutson Co-founder Virtual PV Potential for Apps in Pharmaceutical Development Steve Hutson Co-founder Virtual PV Potential for Apps in Pharmaceutical

More information

Is it time for a new drug development paradigm?

Is it time for a new drug development paradigm? Is it time for a new drug development paradigm? Robert McDonough, M.D. Senior Director, Clinical Policy Research and Development 1 The Aetna Way Our Cause To make quality health care more affordable and

More information

Use of Mobile Medical Applications in Clinical Research

Use of Mobile Medical Applications in Clinical Research Use of Mobile Medical Applications in Clinical Research Erin K. O Reilly, PhD RAC Associate Director, Regulatory Affairs Duke Translational Medicine Institute erin.oreilly@duke.edu September 10, 2014 (919)

More information

MA 2000 Pharmacology for Medical Assistants

MA 2000 Pharmacology for Medical Assistants South Central College MA 2000 Pharmacology for Medical Assistants Course Information Description Total Credits 3.00 Total Hours 64.00 Types of Instruction In this course students will learn topics essential

More information

Mobile Medical Applications: An Overview of FDA Regulation

Mobile Medical Applications: An Overview of FDA Regulation Mobile Medical Applications: An Overview of FDA Regulation RAPS Annual Convention 2014 Austin, Texas Michael A. Swit, Esq. Special Counsel, FDA Law Practice Duane Morris LLP Standard Disclaimers The views

More information

EMR Adoption Survey. Instructions. This survey contains a series of multiple-choice questions corresponding to the 5-stage EMR Adoption Model.

EMR Adoption Survey. Instructions. This survey contains a series of multiple-choice questions corresponding to the 5-stage EMR Adoption Model. EMR Adoption Survey Instructions This survey contains a series of multiple-choice questions corresponding to the -stage EMR Adoption Model. If the respondent is a physician, ask all questions. If the respondent

More information

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,

More information

Metastatic breast cancer, HER2 overexpression, first-line therapy in combination with a taxane and trastuzumab

Metastatic breast cancer, HER2 overexpression, first-line therapy in combination with a taxane and trastuzumab COMPENDIA TRANSPARENCY TRACKING FORM DRUG: Carboplatin INDICATION: Metastatic breast cancer, HER2 overexpression, first-line therapy in combination with a taxane and trastuzumab COMPENDIA TRANSPARENCY

More information

JEFFERSON CARDIOLOGY NOTICE OF HEALTH INFORMATION PRACTICES

JEFFERSON CARDIOLOGY NOTICE OF HEALTH INFORMATION PRACTICES JEFFERSON CARDIOLOGY NOTICE OF HEALTH INFORMATION PRACTICES This notice describes how medical information about you may be used and disclosed and how you can get access to this information. Please review

More information

Medical Device Software

Medical Device Software Medical Device Software Bakul Patel Senior Policy Advisor 1 Overview Medical devices and software Oversight principles and Current approach Trends, Challenges and opportunities Addressing challenges 2

More information

Incorporating Pediatric Medication Safety into your Health System

Incorporating Pediatric Medication Safety into your Health System Incorporating Pediatric Medication Safety into your Health System Julie Kasap, Pharm.D. Margaret CHOI Heger, Pharmacy PharmD, Supervisor BCPS January 2015 Pediatric Antimicrobial Stewardship Conference

More information

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction

More information

PGY-1 PHARMACY RESIDENCY

PGY-1 PHARMACY RESIDENCY PGY-1 PHARMACY RESIDENCY PGY-1 Match Number: 135413 Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health

More information

10/4/10. Risë Marie Cleland Rise@Oplinc.com

10/4/10. Risë Marie Cleland Rise@Oplinc.com Risë Marie Cleland Rise@Oplinc.com describe trends increasing the financial risk for practices & patients, understand how financial counseling minimizes this risk identify key tasks & Best Practices in

More information

Objectives. Background

Objectives. Background Development and Implementation of a Pharmacist-Managed Intranasal Naloxone Distribution Program in a Veterans Affairs Healthcare Facility and Associated Community Clinics Innovative Practices Award Finalist

More information

Introduction to Compliance with FDA Labeling and Advertising Requirements

Introduction to Compliance with FDA Labeling and Advertising Requirements Introduction to Compliance with FDA Labeling and Advertising Requirements Second Annual Pharmaceutical Industry Regulatory and Compliance Summit Dick Kenny FDA History Basic function of government Oldest

More information

EVALUATION/PRIORITIZATION CRITERIA: C, L, R, S *to meet requirement 1

EVALUATION/PRIORITIZATION CRITERIA: C, L, R, S *to meet requirement 1 COMPENDIA TRANSPARENCY TRACKING FORM DATE: MAY 2015 PACKET: 111 DRUG: INDICATION: Vinorelbine Tartrate Malignant pleural mesothelioma COMPENDIA TRANSPARENCY REQUIREMENTS 1 Provide criteria used to evaluate/prioritize

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

U.S. Department of Health and Human Services (HHS) The Office of the National Coordinator for Health Information Technology (ONC)

U.S. Department of Health and Human Services (HHS) The Office of the National Coordinator for Health Information Technology (ONC) U.S. Department of Health and Human Services (HHS) The Office of the National Coordinator for Health Information Technology (ONC) Security Risk Assessment (SRA) Tool User Guide Version Date: March 2014

More information

Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary

Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary Mayo Clinic College of Medicine Pharmacy Services Rotation Summary Rotation Title: PGY-2 Pediatric Hematology-Oncology Rotation Length: 3-6 weeks Primary Preceptor Name: Amanda Kuper, PharmD, BPCS, Ron

More information

Connected drug delivery systems : Increase patient compliance and enable comprehensive, coordinated treatments

Connected drug delivery systems : Increase patient compliance and enable comprehensive, coordinated treatments Connected drug delivery systems : Increase patient compliance and enable comprehensive, coordinated treatments Eric Dessertenne, PharmD, MBA Head of Business Development & Commercial Operations edessertennne@biocorp.fr

More information

SURGICAL CENTER FOR EXCELLENCE PATIENT INFORMATION

SURGICAL CENTER FOR EXCELLENCE PATIENT INFORMATION As a person with pain, you have the right to: SURGICAL CENTER FOR EXCELLENCE PATIENT INFORMATION PAIN CARE BILL OF RIGHTS Have your report of pain taken seriously and to be treated with dignity and respect

More information

We ask that you allow our office 24-48 hours to respond to telephone messages and callbacks.

We ask that you allow our office 24-48 hours to respond to telephone messages and callbacks. NOTICE OF PRIVACY PRACTICE Associated Physicians Group This notice describes how your medical information may be disclosed and how you can get access to this information. Please review these policies carefully.

More information

Which Apps Does FDA Regulate?

Which Apps Does FDA Regulate? Which Apps Does FDA Regulate? Bradley Merrill Thompson 2015 EPSTEIN BECKER & GREEN, P.C. ALL RIGHTS RESERVED.. 1 Topics for Discussion Which apps does FDA regulate? Enforcement Discretion Pharma Apps Future

More information

Clinical Environment:

Clinical Environment: Medicos Consultants Structured Product Labeling (SPL) in the Clinical Environment: Electronic Health Records (EHR) & Digital Medical References (DMR) September 21, 2010 All Rights Reserved. 2010 No part

More information

Top 15 Free Android Medical apps for Healthcare professionals by imedicalapps Team By: Iltifat Husain MD, Brett Einerson MD

Top 15 Free Android Medical apps for Healthcare professionals by imedicalapps Team By: Iltifat Husain MD, Brett Einerson MD The buzz surrounding Android exciting phones, expanding market share, more apps, and even a Medical category on the Market point toward the continued presence of Android in the competition for the hearts,

More information

Specialty Pharmacy? Disclosure. Objectives Technician

Specialty Pharmacy? Disclosure. Objectives Technician Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University

More information

Understanding Our Curriculum

Understanding Our Curriculum Understanding Our Curriculum One question that comes up quiet frequently when talking with preceptors is what are we teaching our students and when are they exposed to certain classes. Below you will find

More information

MOBILE TECHNOLOGY IN PATIENT CARE

MOBILE TECHNOLOGY IN PATIENT CARE MOBILE TECHNOLOGY IN PATIENT CARE Elizabeth Urteaga, Pharm.D. National Wellness Conference June 23, 2014 Learning Objectives Identify mobile instruments available to monitor a patient s disease states

More information

NATURAL MEDICINES TO MANAGE DIABETES

NATURAL MEDICINES TO MANAGE DIABETES NATURAL MEDICINES TO MANAGE DIABETES ACTIVITY DESCRIPTION Some surveys have shown that more than 60 percent of people with diabetes use some type of supplement. There are many supplements which are traditionally

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Leveraging Clinical Decision Support for Optimal Medication Management Anne M Bobb, BS Pharm., Director Quality Informatics Children s Memorial Hospital, Chicago IL, February 20, 2012 DISCLAIMER: The views

More information

PGY-2 ONCOLOGY PHARMACY RESIDENCY

PGY-2 ONCOLOGY PHARMACY RESIDENCY PGY-2 ONCOLOGY PHARMACY RESIDENCY Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health system including

More information

Drug Development Process

Drug Development Process Drug Development Process Original Arthur: Addie D. Anderson CRB Consulting Engineers, Inc. Overview Important milestones establishing our current system of regulations Step-by-step overview of the drug

More information

Health Care 2.0: How Technology is Transforming Health Care

Health Care 2.0: How Technology is Transforming Health Care Health Care 2.0: How Technology is Transforming Health Care Matthew Kaiser, CEBS, SPHR Director, HR Technology and Outsourcing Lockton Kansas City, Missouri The opinions expressed in this presentation

More information

EMR Outcomes Self-Assessment Contents

EMR Outcomes Self-Assessment Contents Contents Introduction... How does it work?... Select Purpose... Patient Care Processes... Registration and Attachment... Scheduler... Referral/Consult... 4 Assessment and Treatment... 5 Assessment-Ordering

More information

Lecture 2. Anis Koubaa

Lecture 2. Anis Koubaa Chapter 1- Introduction Lecture 2 Anis Koubaa Slides from textbook Software Engineering, Ninth Edition by Sommerville (c) Pearson Education 1 - Addison-Wesley, 2011 22-Jun-12 Software engineering ethics

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM BOARD OF PHARMACY SPECIALTIES PHARMACOTHERAPY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2015/FOR USE ON FALL 2016 EXAMINATION AND FORWARD UNDERSTANDING THE CONTENT

More information

CENTER FOR CONNECTED HEALTH POLICY

CENTER FOR CONNECTED HEALTH POLICY CENTER FOR CONNECTED HEALTH POLICY The Center for Connected Health Policy (CCHP) is a public interest nonprofit organization that develops and advances telehealth policy solutions to promote improvements

More information

EDUCATING, MOTIVATING, and EMPOWERING PATIENTS to SAVE MONEY

EDUCATING, MOTIVATING, and EMPOWERING PATIENTS to SAVE MONEY EDUCATING, MOTIVATING, and EMPOWERING PATIENTS to SAVE MONEY 1 AGENDA AGENDA! Company Overview! How Rx Savings Solutions Works! Navigating Your Report! Frequently Asked Questions 2 BACKGROUND! Founded

More information

Ways to find medical information on the Internet. Academic Library of the Medical Faculty CU

Ways to find medical information on the Internet. Academic Library of the Medical Faculty CU Ways to find medical information on the Internet Web search tools Directories Search engines Metasearch tools Things to know about subject directories Assembled by teams of editors who are specialists

More information

RISK EVALUATION AND MITIGATION STRATEGY (REMS)

RISK EVALUATION AND MITIGATION STRATEGY (REMS) Initial REMS approval: 08/2015 NDA 22526 Addyi TM (flibanserin) Serotonin 1A receptor agonist and a Serotonin 2A receptor antagonist Sprout Pharmaceuticals, Inc. 4208 Six Forks Road, Suite 1010 Raleigh,

More information

Requirements for Drug Information Centres

Requirements for Drug Information Centres FIP Pharmacy Information Section Requirements for Drug Information Centres Summary All countries should provide drug information services either independently or as part of a regional network. The service

More information

Concept Series Paper on Electronic Prescribing

Concept Series Paper on Electronic Prescribing Concept Series Paper on Electronic Prescribing E-prescribing is the use of health care technology to improve prescription accuracy, increase patient safety, and reduce costs as well as enable secure, real-time,

More information

How to Achieve Meaningful Use with ICANotes

How to Achieve Meaningful Use with ICANotes How to Achieve Meaningful Use with ICANotes Meaningful use involves using an EHR in a way that the government has defined as meaningful to collect incentive payments. but do not participate. Note: If you

More information

Adoption of Information Technology in Healthcare: Benefits & Constraints

Adoption of Information Technology in Healthcare: Benefits & Constraints Adoption of Information Technology in Healthcare: Benefits & Constraints A WiredFox Technologies White Paper 2 Adoption of Information Technology in Healthcare: Benefits & Constraints By Jeff Yelton 3

More information

Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING

Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING 09-00: PATIENT COUNSELING 09-00-0001--PATIENT INFORMATION, DRUG USE EVALUATION, AND PATIENT COUNSELING The intent of this regulation

More information

BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb.

BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb. BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb.org Content Outline for the PEDIATRIC PHARMACY SPECIALTY CERTIFICATION

More information

Smartphone apps to support hospital prescribing and pharmacology education: a review of current provision

Smartphone apps to support hospital prescribing and pharmacology education: a review of current provision British Journal of Clinical Pharmacology DOI:10.1111/bcp.12112 Smartphone apps to support hospital prescribing and pharmacology education: a review of current provision Faye Haffey, 1 Richard R. W. Brady

More information

Drug Treatment Considerations In The Elderly

Drug Treatment Considerations In The Elderly Drug Treatment Considerations In The Elderly by Gordon Mallarkey Download Drug Treatment Considerations In The Elderly online in pdf Here you can see related and other interesting book : Pharmacotherapy

More information

The iphone as a Medical Device

The iphone as a Medical Device The iphone as a Medical Device Presented by: Melissa L. Markey, Esq. Hall, Render, Killian, Heath & Lyman, PLLC 201 West Big Beaver Rd, Suite 315 Troy, Michigan (248) 740-7505 Hall, Render, Killian, Heath

More information

Complete Pharmacy Technician Certificate Program 230 clock hours

Complete Pharmacy Technician Certificate Program 230 clock hours Complete Pharmacy Technician Certificate Program 230 clock hours Course Description Our Pharmacy Technician Career Training Program will give the pharmacy technician the knowledge to achieve the competencies

More information

HMO Blue Texas SM, Blue Advantage HMO SM and Blue Premier SM Pharmacy

HMO Blue Texas SM, Blue Advantage HMO SM and Blue Premier SM Pharmacy HMO Blue Texas SM, Blue Advantage HMO SM and Blue Premier SM Pharmacy In this Section are references unique to HMO Blue Texas, Blue Advantage HMO and Blue Premier. These network specific requirements will

More information

How Can We Get the Best Medication History?

How Can We Get the Best Medication History? How Can We Get the Best Medication History? Stephen Shalansky, Pharm.D., FCSHP Pharmacy Department, St. Paul s Hospital Faculty of Pharmaceutical Sciences, UBC How Are We Doing Now? Completeness of Medication

More information

How To Prevent Medication Errors

How To Prevent Medication Errors The Academy of Managed Care Pharmacy s Concepts in Managed Care Pharmacy Medication Errors Medication errors are among the most common medical errors, harming at least 1.5 million people every year. The

More information

Guidance for Industry

Guidance for Industry Guidance for Industry IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Hospital pharmacists as part of the Drug & Therapeutics Committee I

Hospital pharmacists as part of the Drug & Therapeutics Committee I Hospital pharmacists as part of the Drug & Therapeutics Committee I EAHP Academy Seminar 20 May, Belgrade Serbia Mag. Gunar Stemer Vienna General Hospital, Pharmacy Department Nothing to disclose. EAHP

More information

TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1.

TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1. 1 Disclaimer The research reports provided by AM Mindpower Solutions are for the personal information of the authorised recipient and is not for public distribution and should not be reproduced or redistributed

More information

EDUCATOR S LESSON PLAN

EDUCATOR S LESSON PLAN EDUCATOR S LESSON PLAN Pharmacy Technician Training Program Student Version Orientation Orientation introduces the student to basic terms and definitions. An introduction to the Pharmacy Technician Certification

More information

Guidance on adverse drug reactions

Guidance on adverse drug reactions Guidance on adverse drug reactions Classification of adverse drug reactions Adverse drug reactions are frequently classified as type A and type B reactions. An extended version of this classification system

More information

practicematters For More Information 888-362-3368 UHCCommunityPlan.com

practicematters For More Information 888-362-3368 UHCCommunityPlan.com Louisiana Fall 2013 practicematters For More Information Call our Provider Service Center at 888-362-3368 Visit UHCCommunityPlan.com In This Issue Admission Notification For Information on Submitting Admission

More information

Mobile Medical Apps. 34% of Adults 34% App = Application; = a self contained program or piece of software designed to fulfill a particular purpose;

Mobile Medical Apps. 34% of Adults 34% App = Application; = a self contained program or piece of software designed to fulfill a particular purpose; Mobile Medical Apps CONSTANTINE GEAN, MD, MS, MBA, FACOEM AOHC 2014 April 30, 2014 DISCLAIMERS ( Aka, My lawyer told me to say nothing I say matters and it s not my fault :) THESE APPS ARE PRESENTED FOR

More information

eschoolpad for ipad INSTALLATION GUIDE v3.0 Prepared by: Avrio Solutions Company Limited

eschoolpad for ipad INSTALLATION GUIDE v3.0 Prepared by: Avrio Solutions Company Limited eschoolpad for ipad INSTALLATION GUIDE v3.0 Prepared by: Avrio Solutions Company Limited Content Version History... 2 Prerequisites for eschoolpad Installation... 3 Step 1: Supervision (for non-supervised

More information

Specialty Pharmacy Definition

Specialty Pharmacy Definition Isn t All of Special? Developing Services Presented to: 2015 ICHP Annual Meeting Presented on: September 10, 2015 Presented by: Lana Gerzenshtein, Pharm.D., BCPS The speaker has no conflicts of interest

More information

Research on Research: Learning about Phase 1 Trials

Research on Research: Learning about Phase 1 Trials CLINICAL CASE STUDY SERIES Research on Research: Learning about Phase 1 Trials Phases of clinical trial investigation are described in some detail in the Code of Federal Regulations. Phase 1 is described

More information

Mobile Data Protection - The Call for Privacy and Security for Wireless PII

Mobile Data Protection - The Call for Privacy and Security for Wireless PII Mobile Data Protection - The Call for Privacy and Security for Wireless PII Agenda moderated by Chris Cwalina The Wireless Ecosystem and Privacy Considerations from an Industry Perspective Kathy Zanowic

More information

Evolution of a Closed Loop Medication Use Process

Evolution of a Closed Loop Medication Use Process Evolution of a Closed Loop Medication Use Process Paul J. Vitale, Pharm.D. pvitale@mdmercy.com Vice President and Chief Pharmacy Officer The Mercy Medical Center Baltimore, Maryland Agenda Hospital Background

More information

Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation

Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Leslie M. Tector Quarles & Brady LLP September 30, 2014 Objectives Which federal

More information

Turning Patient Portals into Major EHR Assets Edward Fotsch, M.D. Douglas Gentile, M.D.

Turning Patient Portals into Major EHR Assets Edward Fotsch, M.D. Douglas Gentile, M.D. Turning Patient Portals into Major EHR Assets Edward Fotsch, M.D. Douglas Gentile, M.D. DISCLAIMER: The views and opinions expressed in this presentation are those of the author and do not necessarily

More information

Japan Internet Medical Association, a specified nonprofit organization

Japan Internet Medical Association, a specified nonprofit organization e-health Code of Ethics 2.0 Japan Internet Medical Association, a specified nonprofit organization Introduction The Internet has dramatically changed the world. Via broadband and improved access from cell

More information

Pharmacy Technician Education for Association Members

Pharmacy Technician Education for Association Members Pharmacy Technician Education for Association Members 1. Pharmacy Payment Models and Methods 0107-0000-14-001-H04-T 0.1 CEU/1.0 Hr Rachel Digmann, PharmD, BCPS Clinical Pharmacy Specialist Telligen This

More information

ios Developer Program Information

ios Developer Program Information apple ios Developer Program Information Introduction The ios Developer Program provides a complete and integrated process for developing and distributing ipad, iphone and ipod touch applications. With

More information

Understanding Your Health Record Information

Understanding Your Health Record Information Associated Retina Consultant s, Ltd. Notice of Information Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE

More information

TRUSTED PATIENT EDUCATION FOR BETTER OUTCOMES. MICROMEDEX Patient Connect. Patient Education & Engagement

TRUSTED PATIENT EDUCATION FOR BETTER OUTCOMES. MICROMEDEX Patient Connect. Patient Education & Engagement TRUSTED PATIENT EDUCATION FOR BETTER OUTCOMES MICROMEDEX Patient Connect Patient Education & Engagement Trusted Patient Education for Better Outcomes All your training, experience, tools, and technology

More information

Macs are not directly compatible with Noetix.

Macs are not directly compatible with Noetix. Those that use Macintosh computers to access Noetix cannot directly access Noetix through http://www.sandiego.edu/noetix. If one is on a Mac and goes to Noetix directly in a web browser, the page is likely

More information

PHARMACY TECHNICIAN CCAPP Accredited Program Provisional Status

PHARMACY TECHNICIAN CCAPP Accredited Program Provisional Status PHARMACY TECHNICIAN CCAPP Accredited Program Provisional Status Program Overview As a result of pharmacists taking a more active role in clinical drug therapy and the counselling of their patients, the

More information

Institutional Pharmacy Advance Practice Experience Transcript

Institutional Pharmacy Advance Practice Experience Transcript Institutional Pharmacy Advance Practice Experience Transcript Student name UM Professional Ability-Based Outcomes 1a. Collect and organize patient data, medical records, interviews, and psychomotor evaluations

More information